These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 20647641)

  • 1. Treatment of Mikulicz's disease with mizoribine.
    Ito S
    Intern Med; 2010; 49(14):1313-4. PubMed ID: 20647641
    [No Abstract]   [Full Text] [Related]  

  • 2. Mikulicz's disease: a long-term follow-up case report.
    Delle Sedie A; Baldini C; Donati V; Mosca M
    Clin Exp Rheumatol; 2012; 30(4):596. PubMed ID: 22931586
    [No Abstract]   [Full Text] [Related]  

  • 3. A case of Mikulicz's disease, IgG4-related plasmacytic syndrome, successfully treated by corticosteroid and mizoribine, followed by mizoribine alone.
    Nanke Y; Kobashigawa T; Yago T; Kamatani N; Kotake S
    Intern Med; 2010; 49(14):1449-53. PubMed ID: 20647666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interdisciplinary approach in a patient with IgG4-associated Mikulicz's disease].
    Triantafyllias K; Karaiskaki N; Hansen T; Galle PR; Schwarting A
    Z Rheumatol; 2013 Nov; 72(9):916-20. PubMed ID: 24129423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relapse patterns in IgG4-related disease.
    Yamamoto M; Takahashi H; Ishigami K; Yajima H; Shimizu Y; Tabeya T; Matsui M; Suzuki C; Naishiro Y; Imai K; Shinomura Y
    Ann Rheum Dis; 2012 Oct; 71(10):1755. PubMed ID: 22589378
    [No Abstract]   [Full Text] [Related]  

  • 6. Mikulicz's recurrent oral aphthae. The effect of hydrocortisone succinate sodium upon the in vitro lymphocyte cytotoxicity.
    Dolby AE
    Br Dent J; 1970 Jun; 128(12):579-80. PubMed ID: 5270335
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of a Japanese traditional medicine, hachimijiogan (kampo), on regulatory CD4+CD25+T cells in Mikulicz's disease.
    Tsuda T; Kobayashi K; Seki K; Yashiro S; Ino T; Kato K; Hanawa T
    Altern Ther Health Med; 2010; 16(2):60-3. PubMed ID: 20232620
    [No Abstract]   [Full Text] [Related]  

  • 8. Beneficial effects of steroid therapy for Mikulicz's disease.
    Yamamoto M; Harada S; Ohara M; Suzuki C; Naishiro Y; Yamamoto H; Takahashi H; Shinomura Y; Imai K
    Rheumatology (Oxford); 2005 Oct; 44(10):1322-3. PubMed ID: 16105910
    [No Abstract]   [Full Text] [Related]  

  • 9. Mikulicz's syndrome: old disease and new view.
    Calguneri M; Kisacik B
    J Rheumatol; 2007 Sep; 34(9):1941. PubMed ID: 17787052
    [No Abstract]   [Full Text] [Related]  

  • 10. Subclinical Riedel's thyroiditis with hypothyroidism coexisting with Mikulicz's disease.
    Nagashima T; Maruyama A; Takatori S; Saito M; Osuga J; Minota S
    Rheumatol Int; 2012 Jun; 32(6):1851-2. PubMed ID: 21833525
    [No Abstract]   [Full Text] [Related]  

  • 11. A case of Mikulicz's disease complicated with severe interstitial nephritis associated with IgG4.
    Aoki A; Sato K; Itabashi M; Takei T; Yoshida T; Arai J; Uchida K; Tsuchiya K; Nitta K
    Clin Exp Nephrol; 2009 Aug; 13(4):367-372. PubMed ID: 19142575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgG4 (IgG4-RD) related diseases, with a horizon not limited to Mikulicz's disease.
    Abud-Mendoza C
    Reumatol Clin; 2013; 9(3):133-5. PubMed ID: 23570964
    [No Abstract]   [Full Text] [Related]  

  • 13. IgG4-related Mikulicz's disease is a multiorgan lymphoproliferative disease distinct from Sjögren's syndrome: a Caucasian patient and literature review.
    Yao Q; Wu G; Hoschar A
    Clin Exp Rheumatol; 2013; 31(2):289-94. PubMed ID: 23406780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double blind trial of an antihistamine drug in the treatment of Mikulicz's recurrent oral aphthae.
    Dolby AE
    Dent Pract Dent Rec; 1968 Jun; 18(10):347-8. PubMed ID: 4870260
    [No Abstract]   [Full Text] [Related]  

  • 15. Elevated IgG4 concentrations in serum of patients with Mikulicz's disease.
    Yamamoto M; Ohara M; Suzuki C; Naishiro Y; Yamamoto H; Takahashi H; Imai K
    Scand J Rheumatol; 2004; 33(6):432-3. PubMed ID: 15794205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The first experience of using rituximab in Mikulicz disease].
    Vasil'ev VI; Pal'shina SG; Simonova MV; Logvinenko OA; Sedyshev SKh; Mitrikov BV; Probatova NA; Kokosadze NV; Safonova TN; Aleksandrova EN; Nasonov EL
    Ter Arkh; 2010; 82(6):62-6. PubMed ID: 20731115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complication of IgG4-related chronic sclerosing dacryoadenitis by lymphoma.
    Cheuk W; Yuen HK; Chan JK
    Arch Ophthalmol; 2008 Aug; 126(8):1170; author reply 1170. PubMed ID: 18695125
    [No Abstract]   [Full Text] [Related]  

  • 18. A new conceptualization for Mikulicz's disease as an IgG4-related plasmacytic disease.
    Yamamoto M; Takahashi H; Ohara M; Suzuki C; Naishiro Y; Yamamoto H; Shinomura Y; Imai K
    Mod Rheumatol; 2006; 16(6):335-40. PubMed ID: 17164992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgG4-Related Disease: Treatment and Insight Into Pathophysiology: Video of the Lecture by John Stone MD, MPH.
    Udell J
    J Clin Rheumatol; 2015 Dec; 21(8):426. PubMed ID: 26587853
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical characteristics of Mikulicz's disease as an IgG4-related disease.
    Moriyama M; Tanaka A; Maehara T; Ohyama Y; Shimizu M; Nakashima H; Hayashida JN; Shinozaki S; Kubo Y; Furukawa S; Kikuta T; Nakamura S
    Clin Oral Investig; 2013 Dec; 17(9):1995-2002. PubMed ID: 23242814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.